In addition, we demonstrated the changes induced in macrophage trogocytosis against RCC cell lines treated with each of the tested VEGFR TKIs (sunitinib, lenvatinib, cabozantinib, and axitinib). The gene discussed is KDR; the disease is renal cell carcinoma.